| If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made. In prior filings Registrant disclosed that it has focused on creating new product lines, building the infrastructure necessary to introduce them under licensing agreements acquired in mid 2005 and phasing out sales of its existing products that were not a part of the licensed products as envisioned by the licensing agreements. Revenues for the first six months of 2006 were approximately $3,848,000 as compared to $1,868,000 for the same period in 2005. We expect to record a net loss of approximately $2,328,000 for the six months ended June 30, 2006, which includes a gain of approximately $2,558,000 on an adjustment to the value of a warrant derivative. Our net loss for the same period last year was approximately $836,000. Our basic and diluted loss per share for the six months ended June 30, 2006 and 2005 is $0.06 and $0.02 respectively. The weighted average shares outstanding for the six months ended June 30, 2006 was 38,394,543 as compared to 33,813,324 for 2005. Revenues for the three months ended June 30, 2006 were approximately $2,482,000 as compared to $809,000 for the same period in 2005. We expect to record a net loss of approximately $220,000 for the three months ended June 30, 2006, which includes a gain of approximately $2,558,000 on an adjustment of the value of a warrant derivative. Our net loss for the same period last year was approximately $485,000. Our basic and diluted loss per share for the three months ended June 30, 2006 and 2005 is $0.01 and $0.01 respectively. The weighted average shares outstanding for the three months ended June 30, 2006 was 38,728,399 as compared to 34,626,647 for 2005. The quarterly review of our financial statements is currently in progress and as such these estimated differences could change based on the final results.
| |